Business Description
Biogen Pharmachem Industries Ltd
ISIN : INE703D01023
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 5.54 | |||||
Interest Coverage | 7347 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 7.76 | |||||
Beneish M-Score | -4.38 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | -0.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.76 | |||||
9-Day RSI | 45.31 | |||||
14-Day RSI | 47.08 | |||||
6-1 Month Momentum % | 56.94 | |||||
12-1 Month Momentum % | 73.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 1.35 | |||||
Cash Ratio | 0.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 62.92 | |||||
Operating Margin % | 110.35 | |||||
Net Margin % | 149.07 | |||||
FCF Margin % | 255.99 | |||||
ROE % | 1.81 | |||||
ROA % | 1.74 | |||||
ROIC % | 1.29 | |||||
ROC (Joel Greenblatt) % | 47.77 | |||||
ROCE % | 1.75 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 54.29 | |||||
PE Ratio without NRI | 54.29 | |||||
PS Ratio | 114 | |||||
PB Ratio | 1.33 | |||||
Price-to-Tangible-Book | 1.34 | |||||
Price-to-Free-Cash-Flow | 43.85 | |||||
Price-to-Operating-Cash-Flow | 43.85 | |||||
EV-to-EBIT | 80.48 | |||||
EV-to-EBITDA | 80.48 | |||||
EV-to-Revenue | 119.97 | |||||
EV-to-FCF | 46.87 | |||||
Price-to-Projected-FCF | 2.24 | |||||
Price-to-Graham-Number | 1.5 | |||||
Earnings Yield (Greenblatt) % | 1.24 | |||||
FCF Yield % | 2.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biogen Pharmachem Industries Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 6.658 | ||
EPS (TTM) (₹) | 0.021 | ||
Beta | 0.03 | ||
Volatility % | 99.94 | ||
14-Day RSI | 47.08 | ||
14-Day ATR (₹) | 0.073105 | ||
20-Day SMA (₹) | 1.161 | ||
12-1 Month Momentum % | 73.85 | ||
52-Week Range (₹) | 0.62 - 1.85 | ||
Shares Outstanding (Mil) | 652.6 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biogen Pharmachem Industries Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biogen Pharmachem Industries Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Biogen Pharmachem Industries Ltd Frequently Asked Questions
What is Biogen Pharmachem Industries Ltd(BOM:531752)'s stock price today?
When is next earnings date of Biogen Pharmachem Industries Ltd(BOM:531752)?
Does Biogen Pharmachem Industries Ltd(BOM:531752) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |